Los Angeles Capital Management & Equity Research Inc. Has $16.96 Million Position in HCA Healthcare Inc (HCA)

Los Angeles Capital Management & Equity Research Inc. cut its position in shares of HCA Healthcare Inc (NYSE:HCA) by 16.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 121,919 shares of the company’s stock after selling 24,810 shares during the quarter. Los Angeles Capital Management & Equity Research Inc.’s holdings in HCA Healthcare were worth $16,961,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Kendall Capital Management boosted its stake in HCA Healthcare by 5.2% in the third quarter. Kendall Capital Management now owns 8,250 shares of the company’s stock valued at $1,148,000 after acquiring an additional 405 shares during the last quarter. Motley Fool Asset Management LLC boosted its stake in HCA Healthcare by 12.5% in the second quarter. Motley Fool Asset Management LLC now owns 3,720 shares of the company’s stock valued at $382,000 after acquiring an additional 412 shares during the last quarter. DNB Asset Management AS boosted its stake in HCA Healthcare by 1.1% in the third quarter. DNB Asset Management AS now owns 36,357 shares of the company’s stock valued at $5,058,000 after acquiring an additional 413 shares during the last quarter. Banque Pictet & Cie SA boosted its stake in HCA Healthcare by 0.5% in the second quarter. Banque Pictet & Cie SA now owns 91,929 shares of the company’s stock valued at $9,432,000 after acquiring an additional 480 shares during the last quarter. Finally, Gideon Capital Advisors Inc. boosted its stake in HCA Healthcare by 14.7% in the second quarter. Gideon Capital Advisors Inc. now owns 4,441 shares of the company’s stock valued at $456,000 after acquiring an additional 569 shares during the last quarter. Institutional investors and hedge funds own 70.84% of the company’s stock.

A number of research analysts have weighed in on the stock. Mizuho reiterated a “buy” rating and issued a $145.00 target price on shares of HCA Healthcare in a research note on Thursday, August 2nd. Barclays assumed coverage on shares of HCA Healthcare in a research note on Tuesday, August 14th. They issued an “overweight” rating and a $150.00 target price on the stock. ValuEngine upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Wednesday, July 18th. Jefferies Financial Group reissued a “buy” rating and issued a $135.00 price target on shares of HCA Healthcare in a research report on Thursday, July 26th. Finally, Credit Suisse Group boosted their price target on shares of HCA Healthcare from $122.00 to $143.00 and gave the company an “outperform” rating in a research report on Friday, July 27th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $141.53.

In related news, SVP Jane D. Englebright sold 6,543 shares of the company’s stock in a transaction that occurred on Wednesday, August 15th. The shares were sold at an average price of $129.86, for a total transaction of $849,673.98. Following the sale, the senior vice president now owns 7,443 shares of the company’s stock, valued at approximately $966,547.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Jane D. Englebright sold 5,081 shares of the company’s stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $141.90, for a total transaction of $720,993.90. Following the sale, the senior vice president now directly owns 16,504 shares in the company, valued at approximately $2,341,917.60. The disclosure for this sale can be found here. Insiders have sold a total of 22,486 shares of company stock worth $3,079,086 in the last ninety days. 2.80% of the stock is currently owned by insiders.

NYSE HCA opened at $143.95 on Friday. HCA Healthcare Inc has a 12-month low of $74.26 and a 12-month high of $144.18. The company has a market capitalization of $48.75 billion, a PE ratio of 15.92, a price-to-earnings-growth ratio of 1.24 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.93 by $0.23. The business had revenue of $11.45 billion for the quarter, compared to analyst estimates of $11.29 billion. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. HCA Healthcare’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.13 EPS. On average, sell-side analysts expect that HCA Healthcare Inc will post 9.35 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be issued a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date of this dividend is Friday, November 30th. HCA Healthcare’s dividend payout ratio (DPR) is presently 21.24%.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by American Banking News and is the property of of American Banking News. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2018/11/10/los-angeles-capital-management-equity-research-inc-has-16-96-million-position-in-hca-healthcare-inc-hca.html.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: Are analyst ratings accurate?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply